Notícias

EBITDA surged 27% as LNG exports hit record levels amid Middle East supply disruptions.

The AI cloud company posted $582 million in revenue for the second quarter, well ahead of Wall Street's estimate of $570 million

Intuitive Machines’ second-quarter revenue grows more than 300% but that’s not enough to please Wall Street.

CENX posted a sharp Q2 profit increase as higher aluminum prices and shipments drove EBITDA to $326.9M, despite a sales miss.

FSTR beat Q2 earnings and revenue estimates as stronger margins, cash flow and backlog support its 2026 outlook.

Argentina headwinds and delayed implementations prompt full-year guidance cut.

Bullish (BLSH) delivered earnings and revenue surprises of +11.11% and +2.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

JD. com (NASDAQ:JD) shares fell around 2% in U.

Burger King U.S. surges past industry peers as Tim Hortons Canada faces headwinds.

Brookfield Corporation (NYSE:BN) shares edged 0. 13% lower in premarket trading after the investment group reported second-quarter adjusted earnings per share below Wall Street expectations.

The AI chip company beat earnings estimates and lifted its 2026 revenue outlook, but shares fell sharply in extended trading

The market seemed more interested in what CEO Elon Musk had to say on SpaceX's first earnings call.

The networking company posted $17.25 billion in quarterly revenue and guided well above Wall Street expectations for the year ahead

JD.com stock was falling on Thursday after the Chinese online retail giant reported earnings. Investors soured on the stock despite better-than-expected results.

Those who bet against Apple often lose in the long run.

JD.com Inc. reported better-than-expected quarterly profit as its food delivery battle with Alibaba Group Holding Ltd. and Meituan cooled down amid regulatory curbs.

Morningstar analysts, however, said Nebius’ high valuation may hold, but a slowdown in AI spending could hinder its ability to attract new capital and sustain growth.

RBC raises its price target on stronger sales, while Bank of America remains cautious ahead of second-quarter earnings.

Atlassian (TEAM) has just reported quarterly results that exceeded analyst expectations, paired with strong guidance that leans heavily on the adoption of its Rovo AI platform and the new Code Context capability. See our latest analysis for Atlassian. Atlassian’s earnings beat and strong Rovo AI narrative have coincided with sharp recent momentum, with a 30 day share price return of 61.44% and a 90 day share price return of 91.99%, even though the 1 year total shareholder return is down...

Vanguard's own 10-year forecast for U.S. stocks is 4.2% to 6.2% a year. The record behind numbers like that is worth seeing whole.

Cisco's fiscal 2026 closes with record $63.3 billion revenue, driven by AI infrastructure demand and a networking super cycle, with projections for continued strong growth in fiscal 2027.

Management's 29% ownership aligns interests as the company deploys idle capacity, resolves legacy disputes, and pursues a transformative $1 billion power lease opportunity.

Company reports $286 million in cash, oversubscribed bookings at $750,000 price point, but pushes first commercial spaceflight to February 2027.

SPRO strengthens its balance sheet and extends cash runway into 2029 while advancing its new SP001 immunology pipeline following the landmark approval of the first oral carbapenem antibiotic.

Spire Global Inc (SPIR) reports its strongest core revenue quarter since the maritime divestiture, with Q2 revenue up 16% year-over-year and active negotiations for an eight-figure NOAA contract.

Enovix Corp (ENVX) reports fifth consecutive quarter of revenue growth, with Smart Eyewear orders jumping nine-fold and drone/defense pipeline expanding to $180 million.

Nano Nuclear Energy Inc (NNE) advances key regulatory milestones and commercial partnerships while managing increased operating costs.

Ondas’ nearly 40% short interest is fueling squeeze hopes as investors watch revenue growth and guidance.

Apple is facing a new chapter as Tim Cook steps down.

BioStem Technologies (OTCMKTS:BSEM) reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from $6.1 million in the first quarter, supported by higher hospital sales, expanded commercial coverage